Home › Funds › SABBY MANAGEMENT, LLC › INM

SABBY MANAGEMENT, LLC position in INM

InMed Pharmaceuticals Inc · Health Care

SABBY MANAGEMENT, LLC reported holding 44,970 shares of INM (InMed Pharmaceuticals Inc) in its Q2 2026 13F filing — a position valued at US$70K, representing 0.51% of its reported portfolio and ranking #16 among its reported holdings. SABBY MANAGEMENT, LLC has disclosed INM holdings in 7 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)44.97K sh
Reported value held$69.70K
Portfolio Weight0.51%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SABBY MANAGEMENT, LLC's INM position evolved

SABBY MANAGEMENT, LLC first disclosed a stake in INM in Q4 2023 at 511,934 shares (US$213.0M). Across 7 filings, SABBY MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 44,970 shares valued at US$70K — a reduction of -175,290 shares quarter over quarter.. Notable position changes include a 29% trim in Q1 2024 (shares fell 27% over the following quarter), a 80% trim in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 511.93K $212.97M New
Q1 2024 361.73K $131.67K Reduce
Q2 2024 307.24K $81.57K Reduce
Q3 2025 220.00K $481.80K New
Q4 2025 201.63K $213.73K Reduce
Q1 2026 220.26K $142.05K Add
Q2 2026 44.97K $69.70K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INM and 13F data

INM (InMed Pharmaceuticals Inc) is a Health Care company. 19 other funds we track also report a position in INM — the largest reported positions include Vivo Capital, LLC (US$1.2M), Squadron Capital Management LLC (US$504K), Ursa Fund Management, LLC (US$195K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INM

All INM fund holders →

FAQ

How long has SABBY MANAGEMENT, LLC held INM?

SABBY MANAGEMENT, LLC has disclosed INM holdings in 7 of the last 11 reported quarters, going back to Q4 2023.

What is SABBY MANAGEMENT, LLC's current position in INM?

As of Q2 2026, SABBY MANAGEMENT, LLC holds 44.97K shares of INM (InMed Pharmaceuticals Inc), valued at $69.70K, representing 0.51% of its reported portfolio and ranking #16.

Has SABBY MANAGEMENT, LLC been buying or selling INM?

In the latest 13F filing (Q2 2026), SABBY MANAGEMENT, LLC reduced its position in INM.

Which other funds hold INM?

Other major institutional holders of INM include Vivo Capital, LLC, Squadron Capital Management LLC, Ursa Fund Management, LLC, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.